Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.50
Bid: 4.00
Ask: 5.00
Change: 0.50 (12.50%)
Spread: 1.00 (25.00%)
Open: 4.00
High: 4.50
Low: 4.00
Prev. Close: 4.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 2023 Trading Update

11 Jul 2023 07:00

RNS Number : 5538F
Norman Broadbent PLC
11 July 2023
 

11 July 2023

Norman Broadbent plc

("Norman Broadbent" or the "Company")

 

H1 2023 TRADING UPDATE

Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, is pleased to announce the following unaudited trading update for the 6 months ended 30 June 2023 ("H1 2023").

 

Financial highlights

· Strong recent growth in net fee income ("NFI") has continued with H1 2023 up 57% to £5.2m (H1 2022: £3.3m).

Q2 2023 NFI of £2.7m was up 50% on Q2 2022 (Q2 2022: £1.8m).

Executive Search NFI grew by 58% to £4.1m (H1 2022: £2.6m). This growth is reflective of the improvements in culture, brand, headcount growth and quality and seniority of mandates secured by the Company.

Interim Management NFI was £1.0m, up 43% on prior year (H1 2022: £0.7m). 

· £1.0m of NFI generated in June 2023 alone.

· H1 2023 EBITDA is expected to be in excess of £0.25m (H1 2022: £0.05m).

· The pipeline of contracted work continues to remain strong with £2.3m of contracted revenue in place going into Q3 2023 (30 June 2022: £1.0m).

· Average new search fee value increased by 43% and average NFI per fee earner up 13% compared to H1 2022. 

· 35% growth in fee earner headcount since 30 June 2022.

· Implementation of improved technology platforms in 2023 with new finance system, HR platform and expense management tool, all of which will provide improved management information and opportunity for rapid expansion.

 

Norman Broadbent expects to announce its unaudited interim results for H1 2023 later this month.

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"We are delighted with the progress the entire business continues to make. Our considerable growth in NFI is translating into positive EBITDA and greatly improved financial performance whilst we continue to invest heavily in business transformation. Having joined the Company in September 2021, a year in which Norman Broadbent delivered a total of £5.8 million NFI, it is very pleasing to see our NFI in H1 2023 alone standing at £5.2 million. This demonstrates just how far the business has come in a relatively short period.

Despite the challenging macro-economic conditions, we have, for some time, believed that the Company is well positioned in the correct markets at the appropriate level to ensure continued growth and success. We are very much on track to deliver on our target of £1.25 million EBITDA by 2025."

 

 

For further Information, please contact:

Norman Broadbent plc   020 7484 0000

Kevin Davidson, CEO

Mehr Malik, CFO

Shore Capital (Nominated Adviser and Broker) 020 7408 4090

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFEFMSEDSEFW
Date   Source Headline
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.